Transcriptional Regulation of Aldehyde Dehydrogenase 1A1 Gene by Alternative Spliced Forms of Nuclear Factor Y in Tumorigenic Population of Endometrial Adenocarcinoma

Genes and Cancer

Volumn 2, Issue 10, 2011, Pages 979-984

  Mamat, Suhana ^a,b   Ikeda, Jun ichiro ^a   Tian, Tian ^a   Wang, Yi ^a   Luo, Wenjuan ^a,c   Aozasa, Katsuyuki ^a   Morii, Eiichi ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b INTERNATIONAL ISLAMIC UNIVERSITY MALAYSIA   (Malaysia)

^c XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

aldehyde dehydrogenase; alternatively spliced isoform; endometrial adenocarcinoma; nuclear factor Y; transcriptional regulation

Indexed keywords

ALDEHYDE DEHYDROGENASE; NUCLEAR FACTOR Y; NUCLEAR FACTOR YA; OCTAMER TRANSCRIPTION FACTOR 1; UNCLASSIFIED DRUG;

ALDEHYDE DEHYDROGENASE 1A1 GENE; ALTERNATIVE RNA SPLICING; ARTICLE; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; GENE CONTROL; GENE EXPRESSION; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; MUTATOR GENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TRANSACTIVATION; TRANSCRIPTION REGULATION;

EID: 84868663721     PISSN: 19476019     EISSN: 19476027     Source Type: Journal    
DOI: 10.1177/1947601911436009     Document Type: Article

References (32)

1. Bonnet D,Dick JE.Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell.Nat Med. 1997;3:730-7.
2. Lessard J,Sauvageau G.Bmi-1 determined the proliferative capacity of normal and leukaemic stem cells.Nature. 2003;423:255-60.
3. Al-Hajj M,Wicha MS,Benito-Hernandez A,Moriison SJ,Clarke MF.Prospective identification of tumorigenic breast cancer cells.Proc Natl Acad Sci U S A. 2003;100:3983-8.
4. Singh SK,Hawkins C,Clarke ID, et al.Identification of human brain tumour initiating cells.Nature. 2004;423:396-401.
5. Reya T,Morrison SJ,Clarke MF,Weissman IL.Stem cells, cancer, and cancer stem cells.Nature. 2001;414:105-11.
6. O'Brien CA,Pollett A,Gallinger S,Dick JE.A human colon cancer cell capable of initiating tumor growth in immunodeficient mice.Nature. 2007;445:106-10.
7. Ricci-Vitiani L,Lombardi DG,Pilozzi E, et al.Identification and expansion of human colon-cancer-initiating cells.Nature. 2007;445:111-5.
8. Kondo T,Setoguchi T,Taga T.Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line.Proc Natl Acad Sci U S A. 2004;101:781-6.
9. Chute JP,Muramoto GG,Whitesides J, et al.Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells.Proc Natl Acad Sci U S A. 2006;103:11707-12.
10. Corti S,Locatelli F,Papadimitriou D, et al.Identification of a primitive brain-derived normal stem cell population based on aldehyde dehydrogenase activity.Stem Cells. 2006;24:975-85.
11. Ginestier C,Hur MH,Charafe-Jauffret E, et al.ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.Cell Stem Cell. 2007;1:555-67.
12. Jiang F,Qiu Q,Khanna A, et al.Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer.Mol Cancer Res. 2009;7:330-8.
13. Matsui W,Wang Q,Barber JP, et al.Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance.Cancer Res. 2008;68:190-7.
14. Pearce DJ,Taussig D,Simpson C, et al.Characterization of cells with a high aldehyde dehydrogenase activity from cord blood and acute myeloid leukemia samples.Stem Cells. 2005;23:752-60.
15. Rasheed ZA,Yang J,Wang Q, et al.Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma.J Natl Cancer Inst. 2010;102:340-51.
16. Su Y,Qiu Q,Zhang X, et al.Aldehyde dehydrogenase 1 A1-positive cell population is enriched in tumor-initiating cells and associated with progression of bladder cancer.Cancer Epidemiol Biomarkers Prev. 2010;19:327-37.
17. Li T,Su Y,Mei Y, et al.ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients' outcome.Lab Invest. 2010;90:234-44.
18. Kastan MB,Schlaffer E,Russo JE,Colvin OM,Civin CI,Hilton J.Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic progenitor cell.Blood. 1990;75:1947-50.
19. Silva IA,Bai S,McLean K, et al.Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival.Cancer Res. 2011;71:3991-4001.
20. Penumatsa K,Edassery SL,Barua A,Bradaric MJ,Luborsky JL.Differential expression of aldehyde dehydrogenase 1a1 (ALDH1) in normal ovary and serous ovarian tumors.J Ovarian Res. 2010;3:28.
21. Deng S,Yang X,Lassus H, et al.Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers.PLoS One. 2010;5:e10277.
22. Rahadiani N,Ikeda J-I,Mamat S, et al.Expression of aldehyde dehydrogenase 1 in endometrioid adenocarcinoma and its clinical implications.Cancer Sci. 2011;102:903-8.
23. Ma I,Allan AL.The role of human aldehyde dehydrogenase in normal and cancer stem cells.Stem Cell Rev. 2011;7:292-306.
24. Yanagawa Y,Chen JC,Hsu LC,Yoshida A.The transcriptional regulation of human aldehyde dehydrogenase 1 gene.J Biol Chem. 1995;270:17521-7.
25. Elizondo G,Medina-Diaz IM,Cruz R,Gonzaiez FJ,Vega L.Retinoic acid modulates retinaldehyde dehydrogenase 1 gene expression through the induction of GADD153-C/EBPβ interaction.Biochem Pharmacol. 2009;77:248-57.
26. Maity S,Sinha S,Ruteshouser E,deCrombrugghe B.Three different polypeptides are necessary for DNA binding of the mammalian heteromeric CCAAT binding factor.J Biol Chem. 1992;267:16574-80.
27. Ishimaru F,Mari B,Shipp MA.The type 2 CD10/neutral endopeptidase 24.11 promoter: functional characterization and tissue-specific regulation by CBF/NF-Y isoforms.Blood. 1997;89:4136-45.
28. Grskovic M,Chaivorapol C,Gaspar-Maia A,Ramalho-Santos M.Systematic identification of cic-regulatory sequences active in mouse and human embryonic stem cells.PLos Genet. 2007;3:e145.
29. Zhu J,Zhang Y,Joe GJ,Pompetti R,Emerson SG.NF-Ya activates multiple hematopoietic stem cell (HSC) regulatory genes and promotes HSC self-renewal.Proc Natl Acad Sci U S A. 2005;102:11728-33.
30. Morii E,Oboki K.MITF is necessary for generation of prostaglandin D2 in mouse mast cells.J Biol Chem. 2004;279:48923-9.
31. Zhang J-W,Tang Q-Q,Vinson C,Lane MD.Dominant-negative C/EBP disrupts mitotic clonal expansion and differentiation of 3T3-L1 preadipocytes.Proc Natl Acad Sci U S A. 2004;101:43-47.
32. Mantovani R,Li X-Y,Pessara U, et al.Dominant negative analogs of NF-YA.J Biol Chem. 1994;269:20340-6.